Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Chorionic Gonadotropin Market Value Expansion And Long-Term Growth Outlook
The market for chorionic gonadotropin has experienced robust expansion in recent years. Projections indicate that its value will increase from $1.34 million in 2025 to $1.43 million in 2026, reflecting a compound annual growth rate (CAGR) of 6.5%. This growth observed during the historical period can be explained by the rising demand for infertility treatments, the well-established use of chorionic gonadotropin for ovulation induction, a growing prevalence of male reproductive disorders, the implementation of fertility programs within hospital settings, and its long history of clinical application.
The chorionic gonadotropin market is anticipated to experience robust expansion over the coming years. By 2030, its value is projected to reach $1.82 million, growing at a compound annual growth rate (CAGR) of 6.2%. This upward trajectory during the forecast period is driven by factors such as the worldwide increase in infertility rates, the broadening scope of assisted reproductive technologies, heightened awareness surrounding male hormonal disorders, a rise in oncology diagnostic uses, and easier access via retail pharmacies. Key developments shaping this period include the growing adoption of chorionic gonadotropin in assisted reproduction procedures, its expanding role in treating male hypogonadism, a surge in demand for fertility hormone therapies, wider diagnostic application as a tumor marker, and advancements in formulation precision and dosing accuracy.
Download A Free Sample Report For Comprehensive Market Insights:
Chorionic Gonadotropin Market Demand Drivers Creating New Revenue Opportunities
The chorionic gonadotropin market is expected to grow in the coming years, driven largely by the rising occurrence of infertility. This condition is defined as the failure to achieve pregnancy following 12 months of regular, unprotected intercourse for couples under 35, or after six months for those aged 35 and above. A key factor behind this growing prevalence is the trend of delayed childbearing, as more people are choosing to start families later in life, along with lifestyle elements like obesity and smoking, which adversely affect reproductive health. Within fertility treatments, Chorionic Gonadotropin (hCG) plays a critical role: it induces ovulation in women, aids the luteal phase to sustain pregnancy, and boosts testosterone production in men to enhance sperm count, thereby addressing diverse infertility challenges. To illustrate, in April 2023, the World Health Organization (WHO), a Switzerland-based specialized agency, noted that about 17.5% of the global adult population—or 1 in 6 individuals—experiences infertility, highlighting a pressing need for better access to affordable, high-quality fertility care. Consequently, the escalating prevalence of infertility issues is fueling expansion in the chorionic gonadotropin market.
The chorionic gonadotropin market is significantly propelled forward by the growing adoption of assisted reproductive technologies. These ART procedures are medical interventions designed to help individuals or couples achieve pregnancy when natural conception is not possible. Their increased use is driven by factors such as rising infertility rates, ongoing medical innovations, the trend of postponing childbirth, and enhanced availability of these services. Specifically, chorionic gonadotropin (hCG) is utilized within ART to trigger ovulation and, after embryo transfer, to support the luteal phase, which is essential for ensuring successful fertilization and maintaining early pregnancy. As a case in point, Cofertility, a US-based healthcare company, reported in May 2024 that egg freezing cycles surged by almost 40% between 2022 and 2023. Thus, the upward trajectory in assisted reproductive technologies is a key force driving the chorionic gonadotropin market’s growth.
Chorionic Gonadotropin Market Segment Analysis: What Are The Major Market Categories?
The chorionic gonadotropin market covered in this report is segmented –
1) By Type: Human Chorionic Gonadotropin, Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain, Other Therapeutic Applications
4) By End User: Research Institutions, Pharmaceutical Companies
Chorionic Gonadotropin Market Trends Driving Strategic Industry Expansion
Key players in the chorionic gonadotropin market are actively working on developing novel products, particularly saliva-based pregnancy tests, with the goal of enhancing convenience, accuracy, and accessibility. This type of test is a non-invasive method that identifies pregnancy by examining a woman’s saliva for the presence of human chorionic gonadotropin (hCG), the hormone produced during pregnancy. In June 2023, for example, Salignostics, a biotechnology firm based in Israel, introduced what is recognized as the first pregnancy test of its kind that uses saliva. With this product, women can determine if they are pregnant by providing a saliva sample instead of urine, and the presence of hCG is detected within 5 to 15 minutes. Called Salistick, this test offers a more comfortable and convenient experience, allowing users to perform it wherever they are and share the result with their partner or loved ones in real time.
Chorionic Gonadotropin Market Leading Companies Driving Competitive Growth
Major companies operating in the chorionic gonadotropin market are Ferring Pharmaceuticals
Access The Complete Chorionic Gonadotropin Market Report:
Chorionic Gonadotropin Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model